West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

Introduction of West Nile (WN) virus into the United States in 1999 created major human and animal health concerns. Currently, no human or veterinary vaccine is available to prevent WN viral infection, and mosquito control is the only practical strategy to combat the spread of disease. Starting with...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Davis, Brent S., Chang, Gwong-Jen J., Cropp, Bruce, Roehrig, John T., Martin, Denise A., Mitchell, Carl J., Bowen, Richard, Bunning, Michel L.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2001
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC114149/
https://ncbi.nlm.nih.gov/pubmed/11287553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.75.9.4040-4047.2001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires